/

Mapp Biopharmaceutical

Developing monoclonal antibody treatments for infectious diseases and biodefense.

BiotechnologyPharmaceuticals mappbio.com ↗

Company facts

Founded: 2003
Employees: 69
Headquarters: United States
Type: Private
Funding: Angel · $900K · 2022
Subsidiaries: LeafBio